Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 avr. 2026 15h00 HE | Source: Asgard Therapeutics

Asgard Therapeutics to present preclinical data on lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026

Asgard Therapeutics to present a poster on its lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026.
25 avr. 2025 04h19 HE | Source: Research and Markets

Cell Reprogramming Industry Report 2025-2030: Market Shares & Forecast by Technology, Application, End User, Region and Company (Shares of Top 5 Market Players, 2024)

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "Cell Reprogramming Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
07 mars 2023 05h23 HE | Source: Research and Markets

Cell Therapy Global Market Report 2023: Sector to Reach $32.1 Billion by 2028 at an 18.66% CAGR

Dublin, March 07, 2023 (GLOBE NEWSWIRE) -- The "Cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
30 nov. 2022 05h03 HE | Source: Research and Markets

Global Cell Therapy Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunity and Forecasts

Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The "Cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...